Effects of allergen and trigger factor avoidance advice in primary care on asthma control: A randomized-controlled trial

Clinical and Experimental Allergy

Volumn 40, Issue 1, 2010, Pages 143-152

  Bobb, C ^b   Ritz, T ^a   Rowlands, G ^c   Griffiths, C ^d  

^a SOUTHERN METHODIST UNIVERSITY   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c LONDON SOUTH BANK UNIVERSITY   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Allergen; Asthma; Asthma management; Education; Primary care; Skin prick test

Indexed keywords

ALLERGEN; SALBUTAMOL; TERBUTALINE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CONTROL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRICK TEST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SELF REPORT; SINGLE BLIND PROCEDURE;

ALLERGENS; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 72949100987     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03350.x     Document Type: Article

References (28)

1. Bethesda ML. National Heart Lung and Blood Institute. Guidelines for the Diagnosis and Management of Asthma (EPR-3). National Heart Lung and Blood Institute, 2007.
2. British Thoracic Society, Scottish Intercollegiate Guidelines Network. BTS/SIGN British guideline on the management of asthma. Thorax 2008 63 (Suppl. IV) : iv1 121.
3. Caress AL, Luker K, Woodcock A, Beaver K. A qualitative exploration of treatment decision-making role preference in adult asthma patients. Health Expect 2002 5 : 223 235.
4. Green RM, Custovic A, Sanderson G et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002 324 : 763.
5. House of Lords Science and Technology Committee. Allergy. London : The Stationery Office, 2007.
6. Gore RB, Bishop S, Durrell B et al. Air filtration units in homes with cats: can they reduce personal exposure to cat allergen? Clin Exp Allergy 2003 33 : 765 769.
7. Gotzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. BMJ 1998 317 : 1105 1110.
8. Morgan WJ, Crain EF, Gruchalla RS et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004 351 : 1068 1080.
9. de Vries MP, van den Bemt L, Aretz K et al. House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial. Br J Gen Pract 2007 57 : 184 190.
10. Bobb C, Ritz T. Do asthma patients in general practice profit from a structured allergy evaluation and skin testing? A pilot study. Respir Med 2003 97 : 1180 1187.
11. Brydon M. Allergy protocol. Practice Nurse 1993 21.
12. Ritz T, Steptoe A, Bobb C, Harris AHS, Edwards M. The asthma trigger inventory: validation of a questionnaire for perceived triggers of asthma. Psychosom Med 2006 68 : 956 965.
13. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999 14 : 902 907.
14. Katz PP, Yelin EH, Eisner MD, Blanc PD. Perceived control of asthma and quality of life among adults with asthma. Ann Allergy Asthma Immunol 2002 89 : 251 258.
15. Wigal JK, Stout C, Brandon M et al. The knowledge, attitude, and self-efficacy asthma questionnaire. Chest 1993 104 : 1144 1148.
16. Steen N, Hutchinson A, McColl E et al. Development of a symptom based outcome measure for asthma. BMJ 1994 309 : 1065 1068.
17. Morris JF, Temple W. Spirometric "lung age" estimation for motivating smoking cessation. Prev Med 1985 5 : 655 662.
18. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ 2001 323 : 1123 1124.
19. Busse W, Koenig SM, Oppenheimer J et al. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily. J Allergy Clin Immunol 2003 111 : 57 65.
20. Greenstone IR, Ni Chroinin MN, Masse V et al. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev 2005, CD005533.
21. Phipatanakul W, Nowak-Wegrzyn A, Eggleston PA et al. The efficacy of montelukast in the treatment of cat allergen-induced asthma in children. J Allergy Clin Immunol 2002 109 : 794 799.
22. Weiner P, Weiner M, Azgad Y. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax 1995 50 : 1270 1273.
23. Ehrs PO, Sundblad BM, Larsson K. Quality of life and inflammatory markers in mild asthma. Chest 2006 129 : 624 631.
24. Kendrick AH, Higgs CM, Whitfield MJ et al. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ 1993 307 : 422 424.
25. Teeter JG, Bleecker ER. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998 113 : 272 277.
26. Woodcock A, Forster L, Matthews E et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003 349 : 225 236.
27. van der Heide S, Kauffman HF, Dubois AE, de Monchy JG. Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers. Eur Respir J 1997 10 : 1217 1223. (Pubitemid 27278236)
28. McDonald E, Cook D, Newman T et al. Effect of air filtration systems on asthma: a systematic review of randomized trials. Chest 2002 122 : 1535 1542.